Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoids and neuroprotection.

R I Grundy1, M Rabuffetti, M Beltramo

  • 1Schering Plough Research Institute, Milan, Italy. robert.grundy@spcorp.com

Molecular Neurobiology
|February 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Density EEG and Multi-Muscle EMG Dataset during Object Prehension with a sensorized Grasping Box in Humans.

Scientific data·2026
Same author

Progestogen priming is not essential to trigger ovulation in seasonal anoestrus ewes injected twice with a synthetic kisspeptin analogue.

Animal : an international journal of animal bioscience·2026
Same author

The kisspeptin system in domestic animals: what we know and what we still need to understand of its role in reproduction.

Domestic animal endocrinology·2020
Same author

Acute and subacute effects of a synthetic kisspeptin analog, C6, on serum concentrations of luteinizing hormone, follicle stimulating hormone, and testosterone in prepubertal bull calves.

Theriogenology·2019
Same author

Towards new strategies to manage livestock reproduction using kisspeptin analogs.

Theriogenology·2017
Same author

Differential actigraphy for monitoring asymmetry in upper limb motor activities.

Physiological measurement·2016
Same journal

Alpha Lipoic Acid Mitigates TBI-Induced Neuroinflammation by Regulating S100B/STIM Signaling via NF-ƙB Pathway.

Molecular neurobiology·2026
Same journal

Edaravone Attenuates Retinal Ganglion Cell Ferroptosis Induced by Ischemia Reperfusion via Inhibiting the p38 MAPK/ATF3 Signaling Pathway.

Molecular neurobiology·2026
Same journal

DEK Loss Induces Task-specific Deficits in Learning and Memory and Reprograms the Hippocampal Transcriptome in Mice.

Molecular neurobiology·2026
Same journal

Calcium Overloading-Induced UBE2O Upregulation Alleviates Neuronal Apoptosis.

Molecular neurobiology·2026
Same journal

Neuroprotective Effects of Tenoxicam and Phenethyl Isothiocyanate in an Aβ₁₋₄₂-Induced Rat Model of Alzheimer's Disease: Modulation of NF-κB/NLRP3 Signaling and Redox Homeostasis.

Molecular neurobiology·2026
Same journal

Harnessing Regulatory T Cells to Modulate Acute Brain Injury: From Mechanisms to Therapy.

Molecular neurobiology·2026
See all related articles

Cannabinoids show therapeutic potential due to their neuroprotective effects, acting via receptor-dependent and independent pathways. Research highlights their promise for conditions like Multiple Sclerosis and brain injuries.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Cannabinoid compounds possess historical therapeutic recognition.
  • Recent advancements in understanding the cannabinoid system have revitalized research interest.
  • The clinical applications of cannabinoids are being re-evaluated.

Purpose of the Study:

  • To review the cellular effects of cannabinoids.
  • To explore receptor-dependent and independent mechanisms of cannabinoid action.
  • To discuss the neuroprotective potential of cannabinoids.

Main Methods:

  • Review of existing literature on cannabinoid pharmacology.
  • Analysis of cellular mechanisms of action.
  • Examination of preclinical and clinical studies.

Related Experiment Videos

Main Results:

  • Cannabinoids exert effects through both receptor-dependent and independent pathways.
  • Potential neuroprotective mechanisms include inhibition of glutamate release, antioxidant, and anti-inflammatory actions.
  • Evidence supports these effects in conditions like cerebral ischemia, brain trauma, and Multiple Sclerosis.

Conclusions:

  • Cannabinoids demonstrate significant neuroprotective properties.
  • These properties stem from diverse cellular mechanisms.
  • Further clinical investigation is warranted for therapeutic development.